HemoClear Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- (In Progress)
- Latest Deal Amount
-
$4.59M
- Investors
-
2
HemoClear General Information
Description
Developer of an autologous blood processing platform designed to improve patient blood management and expand access to autologous transfusion. The company's platform offers gravity-driven blood processing, recovery and retransfusion of a patient's own red blood cells and platelets without electricity or capital equipment, enabling healthcare providers across surgical, trauma, obstetric, critical care, and military settings to reduce dependence on donor blood and improve blood availability.
Contact Information
Website
www.hemoclear.comCorporate Office
- Ceintuurbaan 28
- 8024 AA Zwolle
- Netherlands
Corporate Office
- Ceintuurbaan 28
- 8024 AA Zwolle
- Netherlands
HemoClear Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | $4.59M | In Progress | ||||
| 3. Debt - General | 16-Jun-2020 | Completed | Generating Revenue/Not Profitable | |||
| 2. Accelerator/Incubator | 13-Jun-2020 | $33.2K | $33.2K | Completed | Generating Revenue/Not Profitable | |
| 1. Accelerator/Incubator | 01-Mar-2016 | Completed | Generating Revenue/Not Profitable |
HemoClear Comparisons
Industry
Financing
Details
HemoClear Competitors (4)
One of HemoClear’s 4 competitors is Haemonetics, a Formerly PE-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Haemonetics | Formerly PE-Backed | Boston, MA | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| LivaNova | Formerly VC-backed | London, United Kingdom | ||||
| Fresenius | Corporation | Bad Homburg, Germany |
HemoClear Patents
HemoClear Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4121138-A2 | Blood separation system and blood products | Pending | 20-Mar-2020 | ||
| US-20230173147-A1 | Blood separation system and blood products | Pending | 20-Mar-2020 | ||
| WO-2021187988-A2 | Blood separation system and blood products | Inactive | 20-Mar-2020 | ||
| WO-2021187988-A3 | Blood separation system and blood products | Inactive | 20-Mar-2020 | A61M1/0281 |
HemoClear Signals
HemoClear Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EIT Health | Accelerator/Incubator | |||
| medical2market | Corporation | Minority |
HemoClear FAQs
-
When was HemoClear founded?
HemoClear was founded in 2015.
-
Where is HemoClear headquartered?
HemoClear is headquartered in Zwolle, Netherlands.
-
What is the size of HemoClear?
HemoClear has 5 total employees.
-
What industry is HemoClear in?
HemoClear’s primary industry is Surgical Devices.
-
Is HemoClear a private or public company?
HemoClear is a Private company.
-
What is the current valuation of HemoClear?
The current valuation of HemoClear is .
-
What is HemoClear’s current revenue?
The current revenue for HemoClear is .
-
How much funding has HemoClear raised over time?
HemoClear has raised $33.2K.
-
Who are HemoClear’s investors?
EIT Health and medical2market have invested in HemoClear.
-
Who are HemoClear’s competitors?
Haemonetics, Medtronic, LivaNova, and Fresenius are competitors of HemoClear.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process